Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension

Journal of Cardiovascular Pharmacology

Volumn 23, Issue , 1994, Pages S77-S80

  Meyer, B H ^a   Pauly, N C ^b   Meyer, B ^c   Douret, G ^c   Roex, M ^c   Joehcms, G ^c   Verhulst, A ^c   Wester, A ^c   Lustcrmans, F ^c   Lewis, M ^c   Stanley, N ^c   Moulopoulos, S ^c   Pasz, T ^c   Bouzo, H ^c   Rau, R ^c   Geser, C ^c   Hitzcnberger, G ^c   Crivelli, C ^c  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b SANOFI   (France)

^c NONE

Author keywords

Angiotensin converting enzyme inhibition; Hydrochlorothiazide; Trandolapril

Indexed keywords

HYDROCHLOROTHIAZIDE; PLACEBO; TRANDOLAPRIL;

ADULT; ARTICLE; ASTHENIA; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERANCE; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HOT FLUSH; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SWEATING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INDOLES; MALE; MIDDLE AGED;

EID: 0028145414     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199400234-00015     Document Type: Article

References (10)

1. Croog SH. Levine S. Testa MA. et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986:014:1657-1664.
2. Vlasses PH. Rotmensch HH. Swanson BN. et al. Comparative antihvpertensive effects of enalapril maleate and hydrochlorothiazide, alone and in combination. J Clin Pharmacol 1983:23:
3. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Low-dose captopril for the treatment of mild to moderate hypertension. Arch Intern Med 1984:144:1947-1953.
4. Weinberger MH. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983:5(suppl 3):III132-III138.
5. Gomez HJ. Walker JF. Moncloa F. et al. In: Puschett JB. Greenberg A. eds. Diuretics: chemistry, pharmacology and clinical applications. New York: Elsevier. 1984:263-265.
6. De Bruijn JHB. Orofiamma BA. Pauly NC. for the Investigator Study Group. Efficacy and tolerance of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. J Cardiovasc Pharmacol 1994;23(suppl 4):S60-S64 (this issue).
7. Backhouse CI. Orofiamma B. Pauly NC, for the Investigator Study Group. Long-term therapy with trandolapril, a new non-sulfhydryl ACE inhibitor, in hypertension: a multicenter international trial. J Cardiovasc Pharmacol 1994;23(suppl 4):S86-S90 (this issue).
8. Weinberger MH. Angiotensin converting enzyme inhibitors enhance the antihypertensive efficacy of diuretics and blunt or prevent adverse metabolic effects. J Cardiovasc Pharmacol 1989;13(suppl 3):S1-S4.
9. Ward ThD. The additive effect of fosinopril in patients taking chlorthalidone for the treatment of mild to moderate essential hypertension. A multicenter, placebo-controlled, dose-response study. Drug Invest 1991;3(suppl 4):25-31.
10. Mehta J. Lopez LM, Thorman AD. Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. Am J Cardiol 1988:61:803-806.